Copyright
©The Author(s) 2023.
World J Hepatol. Mar 27, 2023; 15(3): 353-363
Published online Mar 27, 2023. doi: 10.4254/wjh.v15.i3.353
Published online Mar 27, 2023. doi: 10.4254/wjh.v15.i3.353
Ref. | Number of patients | Age range | Abnormal liver function | E-ALT | E-AST | E-ALP | E-GGT | E-TBIL | D-albumi, n (%) |
Alkan et al[19] | 294 | 14 d-18 years | 130 (44.2%) | 15 (5.1%) | 98 (33.3%) | 19 (6.6%) | 26 (8.9%) | 11 (3.8%) | NA |
Esmaeili et al[20] | 18 | 3-10 years | 6 (33.3%) | 5 (27.8%) | 7 (38.9%) | 0 | NA | 3 (16.7%) | 3 (16.7%) |
Liu et al[21] | 46 | 0-1 year | 20 (43.5%) | 11 (25.0%) | 20 (45.5%) | NA | NA | 6 (13.6%) | 8 (18.2%) |
Parri et al[22] | 130 | 0-17 years | NA | 8/68 (11.8%) | 11/60 (18.3%) | NA | NA | NA | NA |
Du et al[23] | 182 | 0-15 years | NA | 9/180 (5.0%) | 24/180 (13.3%) | 11/174 (6.3%) | NA | NA | NA |
Sun et al[24] | 8 | 2 mo-15 years | 4 (50.0%) | 4 (50.0%) | 0 | NA | NA | 0 | NA |
Biomarker | Severe | Moderate | Mild/asymptomatic |
T lymphocyte[45-47] | CD3+↓; CD4+ ↓; CD8+ ↓; CD3+CD4+ ↓; CD3+CD8+ ↓ | CD3+ →; CD4+ →/↑; CD8+ → | CD3+ →; CD4+ →; CD8+ → |
B lymphocyte[23,46] | ↓ | →/↑ | →/↑ |
Innate cell[23,46] | Monocytes ↑; Neutrophils ↑; NK cells ↓ | Monocytes ↑; NK cells ↑; Neutrophils ↓ | Monocytes →; Neutrophils →; NK cells → |
Immunological parameters[23,46] | IgE ↑; IgG ↓; IgA ↑; IgM ↓; C3 ↑/↓; C4 ↑/↓ | IgE →/↑; IgG →/↑; IgA →/↑; IgM →; C3 ↑/↓; C4 ↑ | IgE →/↑; IgG →/↑; IgA →/↑; IgM →; C3 ↑/↓; C4 → |
Inflammatory cytokine[23,46,47] | IL-2 ↑; IL-4 ↑; IL-6 ↑; IL-10 ↑; IFN-γ ↑; TNF-α ↑ | IL-2 →; IL-4 →; IL-6 →; IL-10 ↑; IFN-γ →; TNF-α → | IL-2 →; IL-4 →; IL-6 →; IL-10 →; IFN-γ →; TNF-α → |
Chemokines[49] | CXCL10 →; CXCL8 →; CCL2 → | CXCL10 →; CXCL8 →; CCL2 → | CXCL10 →; CXCL8 →; CCL2 → |
- Citation: Yun YF, Feng ZY, Zhang JJ. COVID-19 and liver dysfunction in children: Current views and new hypotheses. World J Hepatol 2023; 15(3): 353-363
- URL: https://www.wjgnet.com/1948-5182/full/v15/i3/353.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i3.353